Induction of allopeptide-specific human CD4+CD25+ regulatory T cells ex vivo

    Research output: Contribution to journalArticlepeer-review

    172 Citations (Scopus)


    Although CD4+CD25+ regulatory T cells are pivotal in the prevention of autoimmunity and appear to mediate transplantation tolerance, little is known concerning their antigen specificity. Here we describe the induction of a human CD4+CD25+ regulatory T-cell line specific for a defined peptide alloantigen (human leukocyte antigen A2 [HLA-A2] 138-170) by priming purified CD4+CD25+ cells ex vivo. The regulatory cells were anergic and retained their ability to suppress antigen-driven responses of CD4+CD25- cells. They inhibited not only interleukin 2 (IL-2) secretion by CD4+CD25- T cells specific for the same peptide but also direct alloresponse of naive CD4+CD25- T cells stimulated by semiallogeneic dendritic cells (DCs) in the presence of the peptide ("linked suppression"). They also suppressed the response of CD4+ T cells specific for viral and bacterial antigens. The suppressive T-cell line showed sustained high CD25 expression. These findings suggest that peripheral CD4+CD25+ regulatory cells are a precommitted cell lineage from which cells with specificity for non-self-peptides can be selected. This may pave the way for inducing and expanding peptide antigen-specific regulatory T cells ex vivo for cell therapy in transplantation, allergy, and autoimmune disease.
    Original languageEnglish
    Pages (from-to)2180-2186
    Number of pages7
    Issue number6
    Early online date29 May 2003
    Publication statusPublished - 15 Sept 2003


    Dive into the research topics of 'Induction of allopeptide-specific human CD4+CD25+ regulatory T cells ex vivo'. Together they form a unique fingerprint.

    Cite this